AMCP webinar that reviewed proceedings from this Partnership Forum.
AMCP webinar that reviewed proceedings from this Partnership Forum.
Sponsored webinar that discussed topics such as, the RNAi overview, the disease burden of PH1, PH2 and PH3, and an RNAi technology as a potential treatment approach for this rare condition.
Partnership Forum: This forum identified key actions that can support access to and the appropriate management of treatments for rare diseases within the U.S. health care system.
Sponsored webinar that provided an overview of the ATTR amyloidosis disease subtypes, pathophysiology of disease, and the varying clinical presentations, including nonspecific symptoms that should raise suspicion of and aid in diagnosis of the disease.
More than 30 experts representing health plans, integrated delivery systems, health economists, providers, academicians, pharmaceutical manufacturers, and other professionals gathered for AMCP’s Partnership Forum to address the challenges in managing and providing timely access to rare and orphan disease therapies.
Sponsored webinar that educated payers on the important features of axial spondyloarthritis (axSpA) to help with early detection.
Partnership Forum: AMCP convened a stakeholder forum on November 14-15, 2017 to continue the discussion of issues related to oncology management.
The Academy of Managed Care Pharmacy (AMCP) thanks the Pharmacy Quality Alliance (PQA) for the opportunity to provide comments in response to the Call for Comments on PQA Endorsement Consideration of Two New Performance Measures.
Press Release: PRIME Education, Inc. (PRIME), the American Gastroenterological Association (AGA), and the Academy of Managed Care Pharmacy (AMCP), are pleased to announce a groundbreaking initiative in collegial learning between payers and providers to improve treatment decision-making in chronic and costly gastroenterological (GI) diseases.
